Found 14 matching trials
Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer PHASE2 This is a randomized trial for patients with metastatic hormone receptor (H...
Show More Location
University of Alabama at Birmingham (UAB)
Learn More & Join Trial
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer PHASE3 This phase 3 clinical trial compares the efficacy and safety of palazestran...
Show More Location
Clinical Trial Site
Learn More & Join Trial
Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer. PHASE2 This was a randomized, double-blind, placebo-controlled study conducted in ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer PHASE2 A study to evaluate the efficacy and safety of triplet combination of inavo...
Show More Location
Los Angeles Cancer Network - Anaheim
Learn More & Join Trial
A Study to Investigate the Efficacy and Safety of Letrozole SIE Compared With Femara® (Both Combined With the CDK4/6 Inhibitor Ribociclib) in Postmenopausal Women With HR-Positive, HER2-Negative, Inoperable Locally Advanced or Metastatic Breast Cancer PHASE3 The purpose of this study is to evaluate the efficacy and safety of Letrozo...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA) PHASE3 The purpose of the study is to assess the efficacy and safety of the additi...
Show More Location
Alaska Oncology and Hematology
Learn More & Join Trial
Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer PHASE3 The primary purpose of this study was to assess the efficacy of ribociclib,...
Show More Location
Ironwood Cancer and Research Centers
Learn More & Join Trial
Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6) PHASE3 The study is intended to show superiority of AZD9833 in combination with CD...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer PHASE2 This was an open label, multi-center protocol for U.S. patients enrolled in...
Show More Location
Arizona Oncology Associates PC- HAL
Learn More & Join Trial
A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression PHASE2 This was a multi-center, randomized, double blind (investigator and subject...
Show More Location
USC Kenneth Norris Comprehensive Cancer Center Oncology Dept
Learn More & Join Trial